Glycostem
Netherlands - OssBiotechnology
Focus: Glycostem is a newly founded biotechnology company specializing in cellular immunotherapy and growth medium technologies, based in Oss, Netherlands. The company operates in the emerging cell therapy space with a focus on enabling platform technologies.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Glycostem
AI assessmentNot HiringNo open roles listed right now. Follow Glycostem to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
oNKord®
AMLClinical Trials (1)
NCT05290662Registry of Patients Having Received oNKord®
N/AHelp build intelligence for Glycostem
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.